logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table PPP-9. Composition of illicit drug tablets, 2010

Part (i) Content of synthetic scheduled illicit drugs

Country
Number of tabletsMDMA-like Substance {as the only scheduled substances}(Meth)Amphetamine {as the only scheduled substances}MDMA-like Substance and (Meth)Amphetamine {as the only scheduled substances}Other {scheduled substances}MiscellaneousTotal
Belgium(1)12826.63.10.03.966.4100
Bulgaria(1)17720.929.44.50.644.6100
Czech Republic13100.00.00.00.00.0100
Denmark706.00.00.090.04.0100
Germany14089522.715.40.061.90.0100
Estonia(1)1040.40.020.00.399.4100
Ireland:::::::
Greece1279698.50.11.40.00.0100
Spain52174.70.00.02.223.2100
France-A(1)18019.06.00.02.073.0100
France-B3737.813.50.05.443.2100
Italy2848.037.00.00.015.0100
Cyprus4807.00.01.448.343.4100
Latvia(1)1940.40.00.00.099.6100
Lithuania:::::::
Luxembourg4911.70.00.058.829.5100
Hungary(1)1799.511.20.00.678.8100
Malta19787100.00.00.00.00.0100
Netherlands243285.03.03.02.07.0100
Austria(1)8424.06.00.07.063.0100
Poland(1)398.046.02.036.08.0100
Portugal(1)20689.41.20.00.09.4100
Romania:::::::
Slovenia1140.040.010.00.010.0100
Slovakia248739.90.00.00.060.1100
Finland18754.54.05.110.825.6100
Sweden(1)239000.71.40.00.397.6100
United Kingdom(1)283511.01.01.02.085.0100
Croatia(1)3429.414.72.911.841.2100
Turkey981314.069.03.02.012.0100
Norway1829319.01.01.069.010.0100
 

Notes:

The table seeks to monitor synthetic scheduled illicit drugs - i.e. drugs controlled under the 1971 UN Convention on Psychotropic Substances Schedules I and II and under European legislation (Council Decisions), providing data on the contents of illicit drug tablets from different sources (seizures, users' submissions, etc.).

(1) This figure "Number of tablets" refers to the total number of records analysed; that is the number of different tablet types analysed.

For methodological information: source, sampling frame and type of study, please refer to Table PPP-9 part(ii). and Table PPP-9 part(iii).

For additional available information on substances included in categories "Miscellaneous" and "Other", please refer to Table PPP-9 part(iv).

Source:

Reitox national focal points.

Page last updated: Monday, 09 July 2012